[1] Yu K, Li Q, Shi G, et al. Involvement of epithelial-mesenchymal transition in liver fibrosis. Saudi J Gastroenterol, 2018, 24(1):5-11. [2]Higashi T, Friedman S L, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev, 2017, 121:27-42. [3] Keywan M. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review: NADPH oxidase (NOX) and liver fibrosis. Cell Biochem Funct, 2018, 36(6):292-302. [4] Liang S, Kisseleva T, Brenner D A. The role of NADPH oxidases (NOXs) in liver fibrosis and the activation of myofibroblasts. Front Physiol, 2016, 7(138):17. [5] Crosasmolist E, Fabregat I. Role of NADPH oxidases in the redox biology of liver fibrosis. Redox Biol, 2015, 6:106-111. [6] Choi J H, Sun W J, Choi C Y, et al. Capsaicin inhibits dimethylnitrosamine-induced hepatic fibrosis by inhibiting the TGF-β1/Smad pathway via peroxisome proliferator-activated receptor gamma activation. J Agric Food Chem, 2017, 65(2):317-326. [7] Li L, Zhong Y, Ma Z, et al. Methyl ferulic acid exerts anti-apoptotic effects on L-02 cells via the ROS-mediated signaling pathway. Int J Oncol, 2018, 53(1):225-236. [8] Gan D, Zhang W, Huang C, et al. Ursolic acid ameliorates CCl4‐induced liver fibrosis through the NOXs/ROS pathway. J Cell Physiol, 2017, 233(5):6799-6813. [9] Wang G, Yeung C K, Wong W Y, et al. Liver fibrosis can be induced by high salt intake through excess reactive oxygen species (ROS) production. J Agric Food Chem, 2016, 64(7):1610-1617. [10] Yu Y, Sun X, Gu J, et al. Deficiency of DJ-1 ameliorates liver fibrosis through inhibition of hepatic ROS production and inflammation. Int J Biol Sci, 2016, 12(10):1225-1235. [11] Petta S, Valenti L, Svegliati-Baroni G, et al. Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease. J Clin Endocrinol Metab, 2017, 102(8):27-29. [12] Lakner A M, Walling T L, Mckillop I H, et al. Altered aquaporin expression and role in apoptosis during hepatic stellate cell activation. Liver Int, 2015, 31(1):42-51. [13] Bai F, Huang Q, Nie J, et al. Trolline ameliorates liver fibrosis by inhibiting the NF-κB pathway, promoting HSC apoptosis and suppressing autophagy. Cell Physiol Biochem, 2017, 44(2):436-446. [14] Alsamman M, Sterzer V, Meurer S K, et al. Endoglin in human liver disease and murine models of liver fibrosis—A protective factor against liver fibrosis. Liver Int, 2017, 38(5):858-867. [15] Bingül , Başaranküçükgergin C, Aydin A F, et al. Betaine treatment decreased oxidative stress, inflammation, and stellate cell activation in rats with alcoholic liver fibrosis. Environ Toxicol Pharmacol, 2016, 45:170-178. [16] Tian X, Zhao C, Guo J, et al. Carvedilol attenuates the progression of hepatic fibrosis induced by bile duct ligation. BioMed Res Int,2017,(2017-3-15), 2017, 2017:4612769. [17] Szóstek-Mioduchowska A Z, Lukasik K, Skarzynski D J, et al. Effect of transforming growth factor -β1 on α-smooth muscle actin and collagen expression in equine endometrial fibroblasts. Theriogenology, 2019, 124:9-17. |